Hamauchi Satoshi - Division of Gastrointestinal Oncology, Shizuoka Cancer Center Hospital

基本信息

浏览量：38

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 113 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Enfortumab Vedotin (EV) in Previously Treated Gastric/esophageal Cancers Cohorts of EV-202

Kei Muro,Keisho Chin, Steven Brad Maron, Fadi S. Braiteh,Seiichiro Mitani, Hiroki Hara,Yasutoshi Kuboki,Mary F. Mulcahy, Joaquina Celebre Baranda, Faithlore Patrice Gardner, Ning Jin,Satoshi Hamauchi, Jason Kaplan, Seema Rao Gorla, Shubin Liu,Michele Wozniak, Changting Meng,Shunsuke Kondo

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

Impact of Relative Cisplatin Dose to Skeletal Muscle Mass on Adverse Events in Patients with Head and Neck Cancer Undergoing Chemoradiotherapy

Satoshi Suzuki,Tomoya Yokota,Akifumi Notsu,Satoshi Hamauchi,Yusuke Onozawa,Kunihiro Fushiki,Kotoe Oshima,Takeshi Kawakami,Takahiro Tsushima,Hirofumi Yasui,Hirofumi Ogawa,Tsuyoshi Onoe, Keisuke Kawatani,Kentaro Yamazaki

ONCOLOGIST (2024)

引用0浏览0WOS引用

Lenvatinib Rechallenge after Failure of Lenvatinib and Sorafenib in Metastatic Thyroid Cancer

Tomoya Yokota,Satoshi Hamauchi,Takeshi Kawakami,Kunihiro Fushiki

INVESTIGATIONAL NEW DRUGSno. 4 (2024): 361-368

引用0浏览0WOS引用

Real-world Data of Anamorelin in Advanced Gastrointestinal Cancer Patients with Cancer Cachexia

Ari Nishimura,Satoshi Hamauchi,Akifumi Notsu,Kunihiro Fushiki,Kotoe Oshima,Takahiro Tsushima,Takeshi Kawakami,Akiko Todaka,Tomoya Yokota,Hirofumi Yasui,Yusuke Onozawa,Kentaro Yamazaki

BMC Palliative Careno. 1 (2024): 1-8

引用0浏览0WOS引用

The Efficacy and Safety of Anamorelin among Patients with Diabetes

Kenju Ando,Tateaki Naito,Satoshi Hamauchi,Keita Miura, Yuichiro Nishibori, Ayumi Tonsho, Suguru Matsuda,Meiko Morita,Motoki Sekikawa,Kosei Doshita,Hiroaki Kodama,Michitoshi Yabe,Noboru Morikawa,Yuko Iida,Nobuaki Mamesaya,Haruki Kobayashi,Ko Ryo,Kazushige Wakuda,Akira Ono,Hirotsugu Kenmotsu,Haruyasu Murakami,Kentaro Yamazaki,Toshiaki Takahashi

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGYno. 8 (2024): 1115-1121

引用0浏览0WOS引用

1521P Efficacy and Safety of Liposomal Irinotecan Plus S-1 in Patients with Metastatic Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Chemotherapy: Result of a Phase I/II Study

H. Imaoka, M. Ikeda,M. Ozaka, K. Oshima, N. Okano, S. Shimizu, H. Tsumura, Y. Komatsu, T. Yamashita, S. Kataoka, H. Nagano, T. Hisano, M. Sasaki, S. Kobayashi, T. Fukushima, S. Mitsunaga, T. Furukawa,S. Hamauchi, F. Hedouin-Biville, M. Ueno

Annals of Oncology (2024)

引用0浏览0引用

P22-2 A Single Center Treatment Experience of Combination with Chemotherapy and Nivolumab for HER2-negative Gastric Cancer

Kai Tsugaru,Takeshi Kawakami,Daiki Kawaguchi,Ari Nishimura,Kunihiro Fushiki,Kotoe Oshima,Takahiro Tsushima,Akiko Todaka,Satoshi Hamauchi,Tomoya Yokota,Yusuke Onozawa,Hirofumi Yasui,Kentaro Yamazaki

Annals of oncology（2023）

引用0浏览0引用

Biomarker Analysis for Patients with Pancreatic Cancer Treated with Nanoliposomal Irinotecan Plus 5-Fluorouracil/leucovorin

Takeshi Kawakami,Akiko Todaka,Kotoe Oshima,Kunihiro Fushiki,Satoshi Hamauchi,Takahiro Tsushima,Tomoya Yokota,Yusuke Onozawa,Hirofumi Yasui,Kentaro Yamazaki

BMC cancerno. 1 (2023)

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn